Standard & Poor’s has announced that Apple Inc. will join its S&P 100 index of large blue-chip companies, replacing biotech company MedImmune Inc. following the end of trading on Thursday. MedImmune is leaving the index due to its pending acquisition by AstraZeneca. “Shares of companies joining the S&P [indexes] often rise because many portfolio managers try to track the index, and are required to buy stocks that enter it,” reports Reuters. Introduced in 1983, the S&P 100 measures large cap company performance. Apple Inc. stock finished the trading day Wednesday at an all-time closing high of $118.77 per share.
- New Apple Card customers can enjoy up to 6 percent daily cash in new promo
- Ucam Private Home Security Camera is 21% off
- Grab the New 10.2 inch 32GB Apple iPad for Just $299
- MLB App removed On 3rd Gen Apple TV
- Apple TV+ ‘Roar’ to star Alison Brie and Nicole Kidman
- M1 MacBook Air: Long-term review!
- iOS 14.5 beta features improved subscription sheet
- Super Boost WiFi Repeater is 61% off
- Avanca T1 Bluetooth wireless earbuds are 50% off
- Bring your files everywhere with the SanDisk 1TB portable SSD, now only $150